{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T13:58:12Z","timestamp":1774015092308,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"STDF","doi-asserted-by":"publisher","award":["43554"],"award-info":[{"award-number":["43554"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ejphar.2026.178614","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:02:07Z","timestamp":1769616127000},"page":"178614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sustained alogliptin elicits superior control of glycemia and related complications in diabetic rats: Effects on vital organs functions, biochemistry, and structure"],"prefix":"10.1016","volume":"1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7280-2027","authenticated-orcid":false,"given":"Mariam Mohamedy","family":"Eladawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6838-6945","authenticated-orcid":false,"given":"Hany M.","family":"El-Bassossy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2314-6144","authenticated-orcid":false,"given":"Shaimaa S.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.178614_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41598-019-57268-z","article-title":"Interference with AGEs formation and AGEs-induced vascular injury mediates curcumin vascular protection in metabolic syndrome","volume":"10","author":"Ahmed","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.178614_bib2","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.jvs.2013.04.048","article-title":"Orally administered dipeptidyl peptidase-4 inhibitor (Alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats","volume":"59","author":"Bao","year":"2014","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.ejphar.2026.178614_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2957","article-title":"Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes","volume":"34","author":"Bouchi","year":"2018","journal-title":"Diabetes\/metabolism research and reviews"},{"key":"10.1016\/j.ejphar.2026.178614_bib4","article-title":"Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: a systemic review and meta-analysis","volume":"13","author":"Chai","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.178614_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13098-017-0247-8","article-title":"Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients","volume":"9","author":"Chen","year":"2017","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.ejphar.2026.178614_bib6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.31925\/farmacia.2024.2.22","article-title":"Dosage of streptozotocin for inducing models of diabetes mellitus in obesity rats with endothelial dysfunction","volume":"72","author":"Clim","year":"2024","journal-title":"FARMACIA"},{"key":"10.1016\/j.ejphar.2026.178614_bib9","article-title":"A comprehensive review of metabolic syndrome and its role in cardiovascular disease and type 2 diabetes mellitus: mechanisms, risk factors, and management","volume":"16","author":"Dhondge","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2026.178614_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121210","article-title":"Moxonidine ameliorates cardiac injury in rats with metabolic syndrome by regulating autophagy","volume":"312","author":"El-Sayed","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2026.178614_bib11","first-page":"1","article-title":"Histopathological alteration in STZ-nicotinamide diabetic rats, a complication of diabetes or a toxicity of STZ","volume":"5","author":"Elamin","year":"2018","journal-title":"Int .J. Diabetes Clin. Res."},{"key":"10.1016\/j.ejphar.2026.178614_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-021-01382-8","article-title":"Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial","volume":"20","author":"Ferreira","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2026.178614_bib13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1590\/2359-3997000000316","article-title":"Relationships between adiponectin levels, the metabolic syndrome, and type 2 diabetes: a literature review","volume":"61","author":"Frankenberg","year":"2017","journal-title":"Arch. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2026.178614_bib14","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1177\/0954411920921628","article-title":"Mechanics of the dicrotic notch: an acceleration hypothesis","volume":"234","author":"Gamrah","year":"2020","journal-title":"Proc. IME H J. Eng. Med."},{"key":"10.1016\/j.ejphar.2026.178614_bib15","first-page":"9265","volume":"vol. 15","author":"Gourishetti","year":"2020"},{"key":"10.1016\/j.ejphar.2026.178614_bib16","first-page":"2321","volume":"vol. 397","author":"Hamdy","year":"2024"},{"key":"10.1016\/j.ejphar.2026.178614_bib17","article-title":"Physiology, pulse pressure, StatPearls","author":"Homan","year":"2024"},{"key":"10.1016\/j.ejphar.2026.178614_bib18","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3390\/pharmaceutics14091867","article-title":"Investigation of alogliptin-loaded in situ gel implants by 23 factorial design with glycemic assessment in rats","volume":"14","author":"Ibrahim","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejphar.2026.178614_bib19","series-title":"Experimentally Induced Rodent Models of Type 2 Diabetes, Animal Models in Diabetes Research","first-page":"161","author":"Islam","year":"2012"},{"key":"10.1016\/j.ejphar.2026.178614_bib20","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3803\/EnM.2020.35.2.260","article-title":"Recent updates on vascular complications in patients with type 2 diabetes mellitus","volume":"35","author":"Jung","year":"2020","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2026.178614_bib21","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s40264-019-00857-8","article-title":"Benefit-risk assessment of alogliptin for the treatment of type 2 diabetes mellitus","volume":"42","author":"Kaku","year":"2019","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejphar.2026.178614_bib22","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.4239\/wjd.v12.i12.2087","article-title":"Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes","volume":"12","author":"Kawasaki","year":"2021","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.ejphar.2026.178614_bib23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.joca.2012.02.010","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"20","author":"Kilkenny","year":"2012","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.ejphar.2026.178614_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231164548","article-title":"Insulin resistance and cardiovascular disease","volume":"51","author":"Kosmas","year":"2023","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ejphar.2026.178614_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-016-0372-7","article-title":"Impact of dipeptidyl peptidase-4 inhibitors on serum adiponectin: a meta-analysis","volume":"15","author":"Liu","year":"2016","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejphar.2026.178614_bib26","article-title":"Dipeptidyl-peptidase-IV inhibitors, imigliptin and alogliptin, improve beta-cell function in type 2 diabetes","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.ejphar.2026.178614_bib27","article-title":"Linking chronic inflammation with cardiovascular disease: from normal aging to the metabolic syndrome","volume":"3","author":"Lopez-Candales","year":"2017","journal-title":"J. Nature Sci."},{"key":"10.1016\/j.ejphar.2026.178614_bib28","first-page":"37","article-title":"The role of leptin\/adiponectin ratio in metabolic syndrome and diabetes","volume":"18","author":"L\u00f3pez-Jaramillo","year":"2014","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"key":"10.1016\/j.ejphar.2026.178614_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154833","article-title":"Alogliptin exhibits multifaceted effects in thioacetamide-insulted rats: a novel approach to combating hepatic inflammation and fibrogenesis","volume":"250","author":"Mohammed","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.ejphar.2026.178614_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-12-8","article-title":"Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non-diabetic subjects: a preliminary report","volume":"12","author":"Noda","year":"2013","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ejphar.2026.178614_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.dsx.2017.12.001","article-title":"Elevated cardiac troponin I, creatine kinase and myoglobin and their relationship with cardiovascular risk factors in patients with type 2 diabetes","volume":"12","author":"Odum","year":"2018","journal-title":"Diabetes Metabol. Syndr.: Clin. Res. Rev."},{"key":"10.1016\/j.ejphar.2026.178614_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108715","article-title":"Effects of Centella asiatica on skeletal muscle structure and key enzymes of glucose and glycogen metabolism in type 2 diabetic rats","volume":"112","author":"Oyenihi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.178614_bib33","first-page":"1576","volume":"vol. 59","author":"Pereira","year":"2021"},{"key":"10.1016\/j.ejphar.2026.178614_bib34","first-page":"108","article-title":"Study on total antioxidant status in relation to oxidative stress in type 2 diabetes mellitus","volume":"8","author":"Rani","year":"2014","journal-title":"J. Clin. Diagn. Res.: J. Clin. Diagn. Res."},{"key":"10.1016\/j.ejphar.2026.178614_bib35","series-title":"Diabetes, Statpearls","author":"Sapra","year":"2024"},{"key":"10.1016\/j.ejphar.2026.178614_bib36","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1161\/CIRCULATIONAHA.111.041418","article-title":"Chronic DPP-4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis","volume":"124","author":"Shah","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2026.178614_bib37","series-title":"Alogliptin, Statpearls","author":"Terrell","year":"2024"},{"key":"10.1016\/j.ejphar.2026.178614_bib38","article-title":"Role of leptin in obesity, cardiovascular disease, and type 2","volume":"25","author":"Vilari\u00f1o-Garc\u00eda","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2026.178614_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/14756366.2020.1844680","article-title":"Inhibitory evaluation of Curculigo latifolia on \u03b1-glucosidase, DPP (IV) and in vitro studies in antidiabetic with molecular docking relevance to type 2 diabetes mellitus","volume":"36","author":"Zabidi","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejphar.2026.178614_bib40","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ejphar.2016.09.008","article-title":"PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals","volume":"791","author":"Zakaria","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.178614_bib41","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1080\/10837450.2024.2407852","article-title":"Sustained linagliptin administration: superior glycemic control and less pancreatic injury in diabetic rats","volume":"29","author":"Zakaria","year":"2024","journal-title":"Pharmaceut. Dev. Technol."},{"key":"10.1016\/j.ejphar.2026.178614_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/704045","article-title":"The characterization of high\u2010fat diet and multiple low\u2010dose streptozotocin induced type 2 diabetes rat model","volume":"2008","author":"Zhang","year":"2008","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ejphar.2026.178614_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-018-0803-z","article-title":"Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits","volume":"17","author":"Zhang","year":"2018","journal-title":"Cardiovasc. Diabetol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926000968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T11:44:22Z","timestamp":1774007062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926000968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":41,"alternative-id":["S0014299926000968"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178614","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained alogliptin elicits superior control of glycemia and related complications in diabetic rats: Effects on vital organs functions, biochemistry, and structure","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.178614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178614"}}